News & Analysis on Clinical Trial Services & Contract Research And Development
With safety a key issue amongst drug researchers and manufacturers, Genaissance Pharmaceuticals has expanded its genetic testing service, which can analyse key cardiac ion channel proteins involved in drug-induced cardiac arrhythmias.
Dharmacon and Genentech have entered into a collaboration in which RNA interference (RNAi) technology is to be used in future drug discovery and development research. One focus of the deal is gene silencing, a powerful and increasingly used new...
NMR specialists Bruker Biospin launches the 400 MHz 5mm DCH CryoProbe, a cryogenically cooled probe that greatly increases sensitivity and lower detection limits than standard probes.
A new type of antidepressant drug with a novel mechanism of action, which acts on a new target, has entered Phase I clinical trials. The drug could represent a new generation of psycho-active compounds that are devoid of the problems seen with...
A new potential diabetes drug from Dia-B Tech, which is based on a naturally occurring peptide consisting of four amino acids, promises convenience and fewer side effects over current day treatments for type 2 diabetes.